Asian Private Equity Giant PAG To Invest Up To $200 Million In Indian Drugmaker
Hong Kong-based PAG is investing as much as $200 million in Indian drugmaker RK Pharma, the latest deal by the Asian private equity giant in the world’s most populous country and the fastest-growing major economy.
Hong Kong-based PAG is investing as much as $200 million in Indian drugmaker RK Pharma, the latest deal by the Asian private equity giant in the world’s most populous country and the fastest-growing major economy.
What's Your Reaction?
